Lv12
70 积分 2024-03-20 加入
Management of autoimmune and viral hepatitis in immunotherapy: a narrative review
5小时前
待确认
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
11小时前
已完结
EASL Clinical Practice Guidelines: Drug-induced liver injury
1天前
已完结
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
1个月前
已完结
Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) predicts succeeding onset of immune-related adverse events (irAEs)
5个月前
已关闭
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
5个月前
已关闭
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
6个月前
已完结
Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
6个月前
已完结
Eosinophilia during treatment of immune checkpoint inhibitors (ICIs) predicts succeeding onset of immune-related adverse events (irAEs)
6个月前
已完结
Erratum to "Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors" [Lung Cancer 150 (2020) 76-82]
6个月前
已关闭
皖公网安备34019202002308
